All Stories

  1. Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products

    Article • Vaccine, May 2014, Elsevier

    Rebecca Sheets

  2. Opinion on adventitious agents testing for vaccines: Why do we worry so much about adventitious agents in vaccines?

    Article • Vaccine, June 2013, Elsevier

    Rebecca Sheets

  3. Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety

    Article • Biologicals, March 2013, Elsevier

    Rebecca Sheets

  4. Adventitious agents, new technology, and risk assessment, 19–20 May 2011, Baltimore, MD

    Article • Biologicals, March 2012, Elsevier

    Rebecca Sheets

  5. Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products

    Article • Biologicals, November 2011, Elsevier

    Rebecca Sheets

  6. Mode of action of adjuvants: Implications for vaccine safety and design

    Article • Biologicals, September 2010, Elsevier

    Rebecca Sheets

  7. An overview of animal cell substrates for biological products

    Article • Biologicals, November 2008, Elsevier

    Rebecca Sheets

  8. Inclusion of Adolescents in Preventive HIV Vaccine Trials

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2008, Wolters Kluwer Health

    Rebecca Sheets

  9. Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Differing Adenovirus Serotype Vector, Manufacturer's Construct, or Gene In...

    Article • Journal of Immunotoxicology, January 2008, Taylor & Francis

    Rebecca Sheets

  10. Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells

    Article • PLoS Pathogens, February 2007, PLOS

    Rebecca Sheets

  11. Assaying Potency of Novel Vaccines

    Article • Expert Review of Vaccines, June 2006, Taylor & Francis

    Rebecca Sheets

  12. Current advances and challenges in HIV-1 vaccines

    Article • Current HIV/AIDS Reports, March 2006, Springer Science + Business Media

    Rebecca Sheets

  13. Vaccine Cell Substrates 2004

    Article • Expert Review of Vaccines, December 2004, Taylor & Francis

    Rebecca Sheets

  14. Current advances in HIV vaccines

    Article • Current HIV/AIDS Reports, March 2004, Springer Science + Business Media

    Rebecca Sheets

  15. Preventive HIV-1 Vaccines

    Article • January 2004, Springer Science + Business Media

    Rebecca Sheets

  16. Workshop Report : Traditional Approach Preventive HIV Vaccines: What Are the Cell Substrate and Inactivation Issues?1

    Article • AIDS Research and Human Retroviruses, May 1998, Mary Ann Liebert Inc

    Rebecca Sheets

  17. Biologically selected recombinants between Feline Leukemia Virus (FeLV) subgroup a and an endogenous FeLV element

    Article • Virology, October 1992, Elsevier

    Rebecca Sheets

  18. Mobile elements bounded by C4A4 telomeric repeats in oxytricha fallax

    Article • Cell, December 1985, Elsevier

    Rebecca Sheets